STAT3 and cancer: A combined approach of targeting high‐invasive OVCA cells by blockading Gln entry into TCA cycle pathways, along with targeting low‐invasive cancer cells by inhibiting Gln synthesis and STAT3, may provide opportunities for addressing heterogeneity in tumors.